In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a β3-adrenoceptor-mediated effect
- 1 July 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 353 (2-3) , 281-287
- https://doi.org/10.1016/s0014-2999(98)00419-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipolytic effects of conventional β3‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4‐adrenoceptorBritish Journal of Pharmacology, 1997
- Functional and molecular evidence for β1‐, β2‐ and β3‐adrenoceptors in human colonBritish Journal of Pharmacology, 1997
- Effects of catecholamines on isolated human colonic smooth muscleJournal of Autonomic Pharmacology, 1996
- Beta 3-adrenoceptor agonists, BRL 37344 and SR 58611A, do not induce relaxation of human, sheep and guinea-pig airway smooth muscle in vitroEuropean Respiratory Journal, 1994
- The human β3-adrenoceptor: the search for a physiological functionTrends in Pharmacological Sciences, 1994
- Tissue distribution of beta 3-adrenergic receptor mRNA in man.Journal of Clinical Investigation, 1993
- Interaction of tertatolol at the “atypical” or beta3-adrenoceptor in guinea-pig ileumGeneral Pharmacology: The Vascular System, 1992
- Colonic and Cardiovascular Actions of the Atypical β‐Adrenergic Agonist SR 58611A in RatsNeurogastroenterology & Motility, 1991
- The brown adipocyte β-adrenoceptorProceedings of the Nutrition Society, 1989
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984